NOTCH3 and acute lymphoblastic leukemia: Here, we investigated effects of HDAC inhibitors (HDACi) in T-ALL and found that pharmacologic or genetic inactivation of HDAC6 is followed by increased lysosomal localization of Notch3, which correlates with a reduction in signaling strength.